April 9, 2025
Pediatric care partners help improve the outpatient experience
At the Reelin’ for Research Pediatric Hematology-Oncology Clinic, a key addition made to the outpatient care team has improved patient care, trust and clinic efficiency.
Tag: Ian Davis
July 26, 2024
Immune cell transformation can influence stem cell transplant success in cancer patients
Jonathan Serody, MD, Ian Davis, MD, PhD, and colleagues report ILC2s can change functions after a patient receives stem cells, thereby preventing a healthy rebuilding of the immune system.
August 9, 2023
Summer funding supports student’s cancer research
UNC-Chapel Hill senior Anna Jin spent her summer in the lab of pediatric oncologist Ian Davis, MD, PhD, researching the use of cancer patients’ own cells to treat Ewing sarcoma.
January 19, 2023
Ian Davis awarded $1 million by V Foundation
UNC Lineberger's Ian Davis, MD, PhD, was awarded $1 million by the The V Foundation to support his work to improve CAR-T therapy for pediatric solid tumors.
March 17, 2022
Local athlete benefits from UNC Lineberger physician’s expertise
Local football player Troy Ennis and his family go through a rare cancer diagnosis and treatment together, relying on the expertise of UNC Lineberger's Ian Davis, MD.
June 1, 2021
Researchers discover gene linked to bone cancer in children, identify potential novel therapy
Pengda Liu, PhD, Ian Davis, MD, PhD, and colleagues have discovered a gene, OTUD7A, that impacts the development of Ewing sarcoma, as well as a compound that shows potential to block OTUD7A protein activity.
April 19, 2019
Study provides insights behind hyperactivation of key cell proliferation signal
The idea was simple: find the faulty signals that drive cancerous growth in cells, and block them. But what University of North Carolina Lineberger Comprehensive Cancer Center researcher Pengda Liu, PhD, has discovered, when it comes to cancer, even straightforward concepts can become complicated. “When you find a target and inhibit it, you find the …